ClinicalTrials.gov record
Active, not recruiting Phase 2 Interventional

A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps

ClinicalTrials.gov ID: NCT06691113

Public ClinicalTrials.gov record NCT06691113. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 3:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of Itepekimab in Participants With Inadequately Controlled Chronic Rhinosinusitis Without Nasal Polyps

Study identification

NCT ID
NCT06691113
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sanofi
Industry
Enrollment
66 participants

Conditions and interventions

Interventions

  • Itepekimab (SAR440340) Drug
  • Mometasone furoate nasal spray (MFNS) Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 15, 2024
Primary completion
Mar 30, 2026
Completion
Aug 17, 2026
Last update posted
May 4, 2026

2024 – 2026

United States locations

U.S. sites
10
U.S. states
7
U.S. cities
10
Facility City State ZIP Site status
Allervie Clinical Research - Birmingham- Site Number : 8400006 Birmingham Alabama 35209
Modena Allergy + Asthma- Site Number : 8400005 La Jolla California 92037
United Medical Doctors - Murrieta- Site Number : 8400001 Murrieta California 92563
Sacramento Ear Nose & Throat - Roseville- Site Number : 8400008 Roseville California 95661
Western States Clinical Research- Site Number : 8400009 Wheat Ridge Colorado 80033
Advanced Research Associates (ARA) Professionals- Site Number : 8400002 Miami Florida 33176
Treasure Valley Medical Research- Site Number : 8400022 Boise Idaho 83706
ENT Associates of Texas - McKinne- Site Number : 8400013 McKinney Texas 75070
Alamo ENT Associates- Site Number : 8400026 San Antonio Texas 78258
Eastern Virginia Medical School (EVMS) Medical Group- Site Number : 8400007 Norfolk Virginia 23510

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 47 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06691113, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 4, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06691113 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →